Avita Medical | 1811094D - Sales Revenues


Avita Medical reported AUD17.61M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
Celltrion KRW 1.24T 90B Jun/2026
Clinuvel Pharmaceuticals AUD 36.93M 22.44M Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 27.58B 730M Jun/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organigram Holdings CAD 59.79M 3.74M Mar/2026
Pacific Edge NZD 5.56M 379K Jun/2026
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
Pharma Mar EUR 50M 7.1M Jun/2026
Polynovo AUD 70.33M 35.75M Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Qiagen NV USD 463.12M 43.9M Jun/2026
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.43B 8.6M Mar/2026
Sartorius EUR 911.8M 12.7M Jun/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026